바이오의약품 시장 : 제품별, 용도별 - 세계 기회 분석과 업계 예측(2022-2030년)
Biopharmaceuticals Market by Product and by Application - Global Opportunity Analysis and Industry Forecast 2022-2030
상품코드 : 1051583
리서치사 : Next Move Strategy Consulting
발행일 : 2022년 01월
페이지 정보 : 영문 277 Pages
US $ 3,975 ₩ 5,255,000
PDF (Single User License)
US $ 4,975 ₩ 6,577,000
PDF (Multi User License)
US $ 6,975 ₩ 9,222,000
PDF (Enterprisewide License)


한글목차

세계의 바이오의약품 시장 규모는 2021년에 3,458억 4,000만 달러로 평가되었습니다. 이 시장은 2022-2030년까지 11.7%의 연평균 복합 성장률(CAGR)로 확대되어 9,744억 8,000만 달러에 달할 것으로 예측됩니다.

암, 심혈관질환(CVD), 당뇨병 등의 만성질환 급증은 바이오의약품 수요를 증가시키는 중요한 요인 중 하나입니다. 고령화 사회 진전에 따른 사회 행동의 급속한 변화가 만성질환 급증을 부르고 있습니다. 중산층 인구 증가와 급속한 도시화에 의해 사람들은 좌식 라이프스타일을 더 유지하게 되었고, 그 결과 비만율이 상승하면서 당뇨병이나 CVD 등의 질병이 증가하고 있습니다.

세계의 바이오의약품(Biopharmaceuticals) 시장에 대해 조사했으며, 시장 개요, 제품별/용도별/지역별 동향 및 시장 진출 기업 프로파일 등을 제공합니다.

목차

제1장 서론

제2장 바이오의약품 시장 - 개요 요약

제3장 시장 개요

제4장 COVID-19 분석

제5장 시장 점유율 분석

제6장 세계의 바이오의약품 시장, 제품별

제7장 세계의 바이오의약품 시장, 용도별

제8장 세계의 바이오의약품 시장, 지역별

제9장 기업 개요

LSH 22.03.03
영문 목차

영문목차

Market Definition:

The Biopharmaceuticals Market was valued at USD 345.84 billion in 2021 and is predicted to reach USD 974.48 billion by 2030 with a CAGR of 11.7% from 2022-2030. Biopharmaceutical products are produced in living organisms including white blood cells or bacteria. Biopharmaceuticals include vaccines, somatic cells, blood components, allergenic, gene therapies, and recombinant therapeutic protein among others. Intravenous, subcutaneous injections and intramuscular are commonly used ways of delivering biopharmaceuticals. Among these, subcutaneous injections are mostly preferred as they require minimal skills and are least invasive. Intramuscular injections are commonly used for vaccines.

Market Dynamics and Trends

Surging incidences of chronic diseases such as cancer, cardiovascular diseases (CVDs), and diabetes, among others is one of the key factors driving the demand for biopharmaceuticals. Also, rapid changes in societal behaviour coupled with growth in aging population are resulting into a surge in chronic diseases. Moreover, growing middle class population and rapid urbanization, leads to people adopting a more sedentary lifestyle. This results in higher obesity rates and diseases such as diabetes and CVDs upward. For instance, around 17.9 million people die every year globally due to cardiovascular diseases, followed by cancer at 9.3 million and respiratory diseases at 4.1 million. In addition to this, rising cancer prevalence in developing economies of Asia Pacific coupled with high consumption of alcohol & tobacco bolsters the industry growth during the review period.

Moreover, high R&D investments plays a critical role in the growth of biopharmaceutical industry. Increasing number of epidemics, changing disease rate, less immunity, and poor efficacy of some drugs creates a robust demand for product innovation, thus R&D helps in creating ample opportunities to the market players.

However, high cost associated with biopharmaceutical drug production is one of the key factors hampering the market growth during the review period. Biopharmaceutical drugs are complex mixtures that comprises of whole cells or derivatives from human, plant, animal, or micro-organism sources, and thus results in expensive manufacturing process of biologics.

Market Segmentations and Scope of the Study:

The biopharmaceuticals market is segmented on the basis of product, application, and geography. On the basis of product, the market is divided into monoclonal antibody, interferon, insulin, growth and coagulation factor, erythropoietin, vaccine, hormone, and others. On the basis of application, the market is categorized into oncology, blood disorder, metabolic disease, infectious disease, cardiovascular disease, neurological disease, immunology, and others. Geographic breakdown and analysis of each of the aforesaid segments includes regions comprising of North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis

North America holds the lion share of biopharmaceuticals market during the forecast period. This is attributed to factors such as strong intellectual property system that encourages innovation through data & patent protection, large presence of scientific research base supported by academic organizations and government research funding, and venture capital investments in start-up biopharmaceutical companies. It has one of the most supportive domestic environments for the production & commercialization of pharmaceuticals with minimal market barriers. Also, presence of major key players such as Pfizer, Johnson & Johnson, and Merck, among others, boosts the market growth in this region.

The Asia Pacific market is likely to register a fastest CAGR in the biopharmaceuticals industry on account of increasing prevalence of cancer, heart diseases, and obesity. In addition to this, rising spending on R&D activities to develop innovate biopharmaceutical products, particularly in China, India, and Japan further augment the regional market growth during the assessment period.

Competitive Landscape

The biopharmaceuticals market comprising of various market players such as Abbott Laboratories, Amgen Inc., Biogen, Lilly, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Merck & Co., Inc., Novo Nordisk, Pfizer Inc., Safoni, AstraZeneca, and Moderna. These market players are adopting various strategies such as agreement, joint venture, and product innovations across various regions to maintain their dominance in the biopharmaceuticals market. For instance, in March 2021, Abbott announced that its team of scientists from Abbott, Johns Hopkins, National Institute of Allergy and Infectious Diseases, University of Missouri have found that the prevalence of HIV elite controllers was 2.7- 4.3% in population from democratic Republic of Congo (DRC).

KEY MARKET SEGMENTS

Biopharmaceuticals Market- by Product

Biopharmaceuticals Market- by Application

Biopharmaceuticals Market- by Geography

TABLE OF CONTENTS

1. INTRODUCTION

2. BIOPHARMACEUTICAL MARKET - EXECUTIVE SUMMARY

3. MARKET OVERVIEW

4. COVID-19 ANALYSIS

5. MARKET SHARE ANALYSIS

6. GLOBAL BIOPHARMACEUTICALS MARKET, BY PRODUCT

7. GLOBAL BIOPHARMACEUTICALS MARKET, BY APPLICATION

8. GLOBAL BIOPHARMACEUTICALS MARKET, BY REGION

9. COMPANY PROFILES

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기